Risk of adalimumab-induced psoriasis in hidradenitis suppurativa versus other inflammatory diseases

J Eur Acad Dermatol Venereol. 2025 May 14. doi: 10.1111/jdv.20743. Online ahead of print.

Authors

Tung S Tran^{1

2

3}, Anh B Q Nguyen², Trang M Nguyen^{1

3}, Edward V Loftus Jr⁴, Courtney A Arment⁵, Doanh H Le^{2

3}, Afsaneh Alavi¹, David A Wetter¹, Giang H Nguyen¹

Affiliations

¹ Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
² Hanoi Medical University, Hanoi, Vietnam.
³ National Hospital of Dermatology and Venereology, Hanoi, Vietnam.
⁴ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
⁵ Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 40365816
DOI: 10.1111/jdv.20743

No abstract available

Publication types

Letter